Literature DB >> 16958675

Methionine adenosyltransferase and S-adenosylmethionine in alcoholic liver disease.

Shelly C Lu1, M Luz Martínez-Chantar, José M Mato.   

Abstract

Methionine adenosyltransferase (MAT) is an essential enzyme that catalyzes the formation of the principal methyl donor S-adenosylmethionine (SAMe). Studies in the past decade have shown that SAMe is not only a methyl donor, but also a key metabolite that regulates hepatocyte growth, death and differentiation. Abnormalities in MAT and decreased SAMe levels occur in experimental animals and humans with alcoholic liver disease. Chronic hepatic SAMe deficiency can result in the spontaneous development of steatohepatitis and hepatocellular carcinoma. This paper reviews MAT genes and SAMe in relation to alcoholic liver disease and the molecular mechanisms by which SAMe regulates hepatocyte growth and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16958675     DOI: 10.1111/j.1440-1746.2006.04575.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  15 in total

Review 1.  Epigenetic regulation in alcoholic liver disease.

Authors:  Pranoti Mandrekar
Journal:  World J Gastroenterol       Date:  2011-05-28       Impact factor: 5.742

2.  Human immunodeficiency virus protease inhibitors modulate Ca2+ homeostasis and potentiate alcoholic stress and injury in mice and primary mouse and human hepatocytes.

Authors:  Eddy Kao; Masao Shinohara; Min Feng; Mo Yin Lau; Cheng Ji
Journal:  Hepatology       Date:  2012-06-11       Impact factor: 17.425

3.  One-carbon metabolism nutrient status and plasma S-adenosylmethionine concentrations in middle-aged and older Chinese in Singapore.

Authors:  Maki Inoue-Choi; Heather H Nelson; Kim Robien; Erland Arning; Teodoro Bottiglieri; Woon-Puay Koh; Jian-Min Yuan
Journal:  Int J Mol Epidemiol Genet       Date:  2012-05-15

Review 4.  Conceptual importance of identifying alcoholic liver disease as a lifestyle disease.

Authors:  Hidekazu Tsukamoto
Journal:  J Gastroenterol       Date:  2007-08-24       Impact factor: 7.527

Review 5.  Alcoholic liver disease: pathogenesis and new therapeutic targets.

Authors:  Bin Gao; Ramon Bataller
Journal:  Gastroenterology       Date:  2011-09-12       Impact factor: 22.682

Review 6.  Hepatoprotective effects of S-adenosyl-L-methionine against alcohol- and cytochrome P450 2E1-induced liver injury.

Authors:  Arthur I Cederbaum
Journal:  World J Gastroenterol       Date:  2010-03-21       Impact factor: 5.742

7.  The role of S-adenosylmethionine in preventing oxaliplatin-induced liver toxicity: a retrospective analysis in metastatic colorectal cancer patients treated with bevacizumab plus oxaliplatin-based regimen.

Authors:  Bruno Vincenzi; Santini Daniele; Anna Maria Frezza; Pierpaolo Berti; Umberto Vespasiani; Antonio Picardi; Giuseppe Tonini
Journal:  Support Care Cancer       Date:  2011-01-14       Impact factor: 3.603

Review 8.  Alcoholic liver disease: pathogenesis, management, and novel targets for therapy.

Authors:  Eric S Orman; Gemma Odena; Ramon Bataller
Journal:  J Gastroenterol Hepatol       Date:  2013-08       Impact factor: 4.029

9.  A decrease in S-adenosyl-L-methionine potentiates arachidonic acid cytotoxicity in primary rat hepatocytes enriched in CYP2E1.

Authors:  Jian Zhuge
Journal:  Mol Cell Biochem       Date:  2008-04-15       Impact factor: 3.396

10.  Liver receptor homolog-1 is a critical determinant of methyl-pool metabolism.

Authors:  Martin Wagner; Sungwoo Choi; Katrin Panzitt; Jennifer L Mamrosh; Jae Man Lee; Alex Zaufel; Rui Xiao; Ruth Wooton-Kee; Marcus Ståhlman; Christopher B Newgard; Jan Borén; David D Moore
Journal:  Hepatology       Date:  2015-10-10       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.